Position in VANI
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$40,000
-$14,493 QoQ
Shares Held
40,000
-9.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VANI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Warberg Asset Management LLC holds $268,217 across 7 Biotechnology names. VANI ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVPH |
Reviva Pharmaceuticals Holdings, Inc.
|
90,772 | $66,236 | |
| 2 | CLDI |
Calidi Biotherapeutics, Inc.
|
250,000 | $59,750 | |
| 3 | OTLK |
Outlook Therapeutics, Inc.
|
275,000 | $56,650 | |
| 4 | VANI |
Vivani Medical, Inc.
This page
|
40,000 | $40,000 | |
| 5 | CLRB |
Cellectar Biosciences, Inc.
|
13,900 | $35,306 | |
| 6 | ERNA |
Ernexa Therapeutics Inc.
|
50,000 | $10,000 | |
| 7 | CRIS |
Curis Inc
|
10,000 | $275 |
All Filings in VANI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,000 | 40,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $54,493 | 44,304 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||